Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$833,907
+$34,719 QoQ
Shares Held
5,321
+1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#686
of 1,603 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 4%
Shared 0%
None 96%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alhambra Investment Management LLC holds $9,363,953 across 10 Drug Manufacturers - General names. NVS ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,705 | $2,210,808 | |
| 2 | AMGN |
Amgen Inc
|
4,329 | $1,567,617 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,112 | $1,299,392 | |
| 4 | LLY |
ELI LILLY & Co
|
1,067 | $1,279,791 | |
| 5 | NVS |
Novartis AG
This page
|
5,321 | $833,907 | |
| 6 | ABBV |
AbbVie Inc.
|
2,924 | $735,795 | |
| 7 | AZN |
Astrazeneca PLC
|
2,840 | $538,520 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,185 | $413,999 |
All Filings in NVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $833,907 | 5,321 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $799,188 | 5,232 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $724,920 | 5,258 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $673,516 | 5,252 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $622,717 | 5,146 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $571,892 | 5,130 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $498,421 | 5,122 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $579,010 | 5,034 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $535,919 | 5,034 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $486,938 | 5,034 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $508,282 | 5,034 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $512,763 | 5,034 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $507,980 | 5,034 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $463,128 | 5,034 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $456,684 | 5,034 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $382,634 | 5,034 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $425,524 | 5,034 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $441,733 | 5,034 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $440,323 | 5,034 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $411,680 | 5,034 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $459,302 | 5,034 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $430,306 | 5,034 | Shares | Sole | 2021-04-16 | |
| No filing history on record for this holder in this stock. | ||||||